
Call us now
07971459530
A combination capsule containing:
Rabeprazole Sodium (Enteric Coated): A proton pump inhibitor (PPI) that suppresses gastric acid secretion by inhibiting the H+/K+ ATPase enzyme in gastric parietal cells.
Levosulpiride (Sustained Release): A prokinetic and antipsychotic agent that enhances gastrointestinal motility and has antiemetic and anxiolytic properties.
This combination is used for acid-related gastrointestinal disorders with motility issues.
Ingredient | Typical Strength | Function |
---|---|---|
Rabeprazole Sodium | 20 mg (Enteric Coated) | Reduces gastric acid secretion |
Levosulpiride SR | 75 mg (Sustained Release) | Enhances gastric motility, antiemetic |
Gastroesophageal reflux disease (GERD)
Peptic ulcers (gastric and duodenal)
Functional dyspepsia
Irritable bowel syndrome with predominant dysmotility
Prevention and treatment of nausea and vomiting
Gastric motility disorders such as gastroparesis
Typical dose: 1 capsule once daily, preferably before meals or as prescribed
Swallow whole; do not crush or chew
Take consistently at the same time each day
Use cautiously in patients with liver or kidney impairment
Avoid in patients with hypersensitivity to any component
May cause extrapyramidal symptoms; use with caution in patients prone to movement disorders
Not recommended during pregnancy and lactation unless prescribed
Inform your doctor about any cardiac or neurological conditions
Common Side Effects | Serious / Rare Side Effects |
---|---|
Headache | Extrapyramidal symptoms (tremors, rigidity) |
Dizziness | Galactorrhea, gynecomastia (rare) |
Abdominal discomfort | Allergic reactions |
Diarrhea | Neuroleptic malignant syndrome (rare) |
Rabeprazole may alter absorption of drugs dependent on stomach acidity (e.g., ketoconazole, digoxin)
Levosulpiride may interact with other CNS depressants or antipsychotics
Use caution with drugs prolonging QT interval
Store at room temperature (below 25C)
Protect from moisture and light
Keep out of reach of children
Price: